There’s currently no reliable screening test for ovarian cancer, meaning that most cases are caught at an advanced stage, ...

Ovarian cancer spreads fast by recruiting the body’s own protective cells to clear the way—and that secret alliance may finally be its undoing.

Breast, cervical and ovarian cancer cases have risen steadily in India over the past five years, with deaths also increasing, ...

Jan 22 (Reuters) - Corcept Therapeutics said on Thursday a late-stage trial showed its experimental drug in combination with chemotherapy helped reduce the risk of death in patients with a type of ...

The study added to a large existing volume of evidence that has consistently shown a risk-reducing effect of OBS on ovarian cancer, said Karen H. Lu, MD, of Moffitt Cancer Center in Tampa, Florida and ...

Women who received Elenagen plus chemotherapy lived significantly longer than those who received chemotherapy alone.

Early menarche, late menopause, and long reproductive span increase ovarian cancer risk, particularly in postmenopausal women ...

Corcept’s overall survival data “look competitive” with AbbVie’s Elahere and Merck’s blockbuster Keytruda, Truist Securities ...

A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a compound derived from the traditional Chinese herb Salvia miltiorrhiza, on ...

Corcept Therapeutics, a pharmaceutical company specialising in cortisol-modulating medications, has announced that its ...